Dr John Buscombe

British Nuclear Medicine Society

Dr John Buscombe is the President of the British Nuclear Medicine Society and works as a Consultant Physician in Nuclear Medicine in Cambridge.

dont miss

Theranostics in prostate cancer new or false dawn

Over the past 2 years new imaging and therapeutic options using radiolabelled prostate specific membrane antigen have been developed which enable us to see disease which cannot be found by other methods with gallium-68 PSMA PET-CT. Newer work has linked this to targeted radionuclide therapy using beta and alpha emitter labelled PSMA is previously untreatable metastatic prostate cancer which is being actively developed.

EVEN MORE SEMINARS

  • Professor Patricia Price: Speaking at the European Neurological Convention

    Professor Patricia Price
    Action Radio Therapy

    Action Radiotherapy -a charity for radiotherapy patients and professionals.

  • Andy Rogers: Speaking at the European Neurological Convention

    Andy Rogers
    Nottingham University Hospitals

    Interventional staff dose reduction: Gaining insight through new technology

  • Dr Sujal Desai: Speaking at the European Neurological Convention

    Dr Sujal Desai
    The Royal Brompton & Harefield NHS Foundation Trust

    An approach to diffuse lung disease: Learn from the experts

  • Dr Sam Hare: Speaking at the European Neurological Convention

    Dr Sam Hare
    Royal Free London NHS Foundation Trust

    How I evaluate lung lesions for CT-guided biopsy?

  • Sabine Sartoretti: Speaking at the European Neurological Convention

    Sabine Sartoretti
    Institut für Radiologie, Kantonsspital Winterthur, Brauerstrasse 15, 8401 Winterthur

    Compressed Sense Technique in Neuroradiology